Awareness and implementation of tobacco dependence treatment guidelines in Arizona: Healthcare Systems Survey 2000

被引:2
|
作者
Gilles M.E. [1 ]
Strayer L.J. [1 ]
Leischow R. [2 ]
Feng C. [1 ]
Menke M.J. [1 ]
Sechrest L. [1 ]
机构
[1] The University of Arizona HealthCare Partnership, Department of Psychology, The University of Arizona, Tucson, AZ
[2] SHPS Inc, Scottsdale, AZ
关键词
Healthcare System; Clinical Practice Guideline; Tobacco Control; Tobacco Cessation; Tobacco Dependence;
D O I
10.1186/1478-4505-6-13
中图分类号
学科分类号
摘要
Background: This paper presents findings from the Tobacco Control in Arizona Healthcare Systems Survey, conducted in 2000. The purpose of the survey was to assess the status of Arizona healthcare systems' awareness and implementation of tobacco cessation and prevention measures. Methods: The 20-item survey was developed by The University of Arizona HealthCare Partnership in collaboration with the Arizona Department of Health Services Bureau of Tobacco Education and Prevention. It was mailed to representatives of Arizona's 40 healthcare systems, including commercial and Medicare managed care organizations, "managed Medicaid" organizations, Veterans Affairs Health Care Systems, and Indian Health Service Medical Centers. Thirty-three healthcare systems (83%) completed the survey. Results: The majority of healthcare systems reported awareness of at least one tobacco cessation and prevention clinical practice guideline, but only one third reported full guideline implementation. While a majority covered some form of behavioral therapy, less than half reported covering tobacco treatment medications. "Managed Medicaid" organizations administered through the Arizona Health Care Cost Containment System were significantly less likely to offer coverage for behavioral therapy and less likely to cover pharmacotherapy than were their non-Medicaid counterparts in managed care, Veterans Affairs Health Care Systems and Indian Health Service Medical Centers. Conclusion: Arizona healthcare system coverage for tobacco cessation in the year 2000 was comparable to national survey findings of the same year. The findings that only 10% of "Managed Medicaid" organizations covered tobacco treatment medication and were significantly less likely to cover behavioral therapy were important given the nearly double smoking prevalence among Medicaid patients. Throughout the years of the program, the strategic plan of the Arizona Department of Health Services Bureau of Tobacco Education and Prevention has included the goal of identifying and eliminating tobacco related disparities for special populations, including low-income groups. Of importance, in 2008 the Arizona Health Care Cost Containment System was authorized to provide tobacco cessation pharmacotherapy as a covered benefit for its members. © 2008 Gilles et al; licensee BioMed Central Ltd.
引用
收藏
相关论文
共 50 条
  • [1] A survey of tobacco dependence treatment guidelines in 31 countries
    Raw, Martin
    Regan, Susan
    Rigotti, Nancy A.
    McNeill, Ann
    [J]. ADDICTION, 2009, 104 (07) : 1243 - 1250
  • [2] A survey of tobacco dependence treatment guidelines in 121 countries
    Pine-Abata, Hembadoon
    McNeill, Ann
    Raw, Martin
    Bitton, Asaf
    Rigotti, Nancy
    Murray, Rachael
    [J]. ADDICTION, 2013, 108 (08) : 1470 - 1475
  • [3] A survey of tobacco dependence treatment guidelines content in 61 countries
    Nilan, Kapka
    McNeill, Ann
    Murray, Rachael L.
    McKeever, Tricia M.
    Raw, Martin
    [J]. ADDICTION, 2018, 113 (08) : 1499 - 1506
  • [4] Awareness and Implementation of the 2000 United States Public Health Service Tobacco Dependence Treatment Guideline in a Public Hospital System
    Moody-Thomas, Sarah
    Horswell, Ronald
    Celestin, Michael D., Jr.
    Dellinger, Amy B.
    Kaiser, Michael
    Butler, Michael
    [J]. POPULATION HEALTH MANAGEMENT, 2011, 14 (02) : 79 - 85
  • [5] Healthcare financing systems for increasing the use of tobacco dependence treatment
    van den Brand, Floor A.
    Nagelhout, Gera E.
    Reda, Ayalu A.
    Winkens, Bjorn
    Evers, Silvia M. A. A.
    Kotz, Daniel
    van Schayck, Onno C. P.
    [J]. COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2017, (09):
  • [6] Healthcare financing systems for increasing the use of tobacco dependence treatment
    Kaper, J
    Wagena, EJ
    Severens, JL
    Van Schayck, CP
    [J]. COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2005, (01):
  • [7] Healthcare financing systems for increasing the use of tobacco dependence treatment
    Reda, Ayalu A.
    Kotz, Daniel
    Evers, Silvia M. A. A.
    van Schayck, Constant Paul
    [J]. COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2012, (06):
  • [8] Healthcare financing systems for increasing the use of tobacco dependence treatment
    Reda, Ayalu A.
    Kaper, Janneke
    Fikrelter, Hurmuz
    Severens, Johan L.
    van Schayck, Constant Paul
    [J]. COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2009, (02):
  • [9] Progress in implementation of WHO FCTC Article 14 and its guidelines: a survey of tobacco dependence treatment provision in 142 countries
    Nilan, Kapka
    Raw, Martin
    McKeever, Tricia M.
    Murray, Rachael L.
    McNeill, Ann
    [J]. ADDICTION, 2017, 112 (11) : 2023 - 2031
  • [10] Critical appraisal of tobacco dependence treatment guidelines
    Maguy Saffouh El Hajj
    Myriam Jaam
    Saba Abdal Salam Sheikh Ali
    Rana Saleh
    Ahmed Awaisu
    Bridget Paravattil
    Kyle John Wilby
    [J]. International Journal of Clinical Pharmacy, 2021, 43 : 85 - 100